Why are cancer outcomes poorer in some population groups in countries with universal access to healthcare? Why does access to optimal cancer care vary between different cancer patients? What are the mechanisms leading to such disparities?
These are the type of questions our research aims to answer. Our ambition is to reduce these inequalities, ensuring that everyone, regardless of their socio-demographic background, benefits from improvements in cancer care. We aim to do this by providing evidence that enables policymakers to address these inequalities through targeted interventions. By identifying and explaining the mechanisms which generate the persisting inequalities in cancer care and survival, we can suggest interventions and evaluate existing and proposed interventions in their ability to reduce inequalities.
Latest posts
- Do presenting symptoms, use of pre-diagnostic endoscopy and risk of emergency cancer diagnosis vary by comorbidity burden and type in patients with colorectal cancer?
What the study found Most people diagnosed with cancer have pre-existing chronic conditions (also known as comorbidities), which might delay the diagnosis of cancer. To better understand which patient groups are at higher risk of delays and where along the […] - Differences in colon cancer survival for patients living and receiving care in London
This study highlights the need to better coordinate primary and secondary care sectors in some areas of London to improve timely access to specialised clinicians and diagnostic tests. - The relation between social factors and health outcomes through social-to-biological processes: Considerations for cancer epidemiology
In this seminar, Michelle Kelly-Irving will outline the embodiment dynamic conceptual framework used to examine how health inequalities are partly constructed through social-to-biological processes. She will provide empirical examples of the social gradient in biological health and how this potentially […] - Statistical methods and recent advances in statistical methods for excess risk analysis.
Corsican Summer School on Modern Methods in Biostatistics and Epidemiology 4th-8th July 2022 - Risk score for pancreatic cancer
PANCREATIC CANCER PATIENTS are usually diagnosed too LATE for curative treatment because there are no early stage symptoms associated with tumour development. - Does the socio-economic level of my area represent my own individual circumstances
Assessment of the concordance between individual-level and area-level measures of socio-economic deprivation in a cancer patient cohort in England and Wales
Social Media Disclaimer
Any follows, reposts, or replies to our social media accounts should not be considered as an endorsement by ICON of any specific messages, opinions or organisations.